Market Overview:
The global P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in the market can be attributed to the increasing demand for P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) in various applications such as esmolol hydrochloride, cetraxate hydrochloride, and others. Moreover, the growing awareness about the benefits of using PHA in various end user industries is also contributing to the growth of this market. However, factors such as high price and limited availability may restrain the growth of this market during the forecast period.
 Industry Outlook.svg)
Product Definition:
P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) is an organic compound with the formula C6H4(OH)COOH. It is a white solid that is soluble in water and polar solvents.
PurityGreater than or equal to99%:
P-Hydroxyphenyl-propionic acid is a naturally occurring organic compound. It is an important intermediate in the production of several industrial chemicals and pharmaceuticals.
PurityBelow99%:
PurityBelow99% is a new term in the market which was created to define a level of purity much higher than 99%. It means that the final product should have less than 1% (w/v) of impurities.
Application Insights:
Esmolol Hydrochloride was the leading application segment and accounted for a market share of more than 60% in 2017. Esmolol is used as an anti-arrhythmic drug to treat various heart diseases such as arrhythmias, heart block, and long QT syndrome. It is also used in the treatment of hypertension and glaucoma. However, ezmo¢â‚¬â„¢s safety profile during pregnancy has raised concerns among healthcare professionals which may restrict its use during future clinical trials.
Cetraxate hydrochloride is expected to be the fastest growing application segment owing to extensive product usage for manufacturing cetyl palmitate which finds numerous applications including cosmetic products (face creams & lotions), personal care products (soaps & shampoos), pharmaceuticals (tonics & syrups) food additives, candles/lamps fragrance industry etcetera.
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to witness substantial growth over the forecast period owing to rising product demand from various end-use industries, such as pharmaceuticals and food & beverage. In addition, increasing healthcare spending by governments of emerging economies such as India and China is anticipated to fuel industry expansion over the coming years.
Growth Factors:
- Increasing demand from end-use industries such as pharmaceuticals, agrochemicals, and cosmetics
- Growing awareness about the benefits of P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) among consumers
- Rising investment in research and development activities for the production of P-Hydroxyphenyl-Propionic Acid (CAS 501-97_3)
- Expansion of manufacturing capacities by key players operating in the market
- Emergence of new applications for P_-Hydroxyphenyl_propionic acid
Scope Of The Report
Report Attributes
Report Details
Report Title
P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Research Report
By Type
PurityGreater than or equal to99%, PurityBelow99%
By Application
Esmolol Hydrochloride, Cetraxate Hydrochloride, Other
By Companies
Jiangsu Xinxin Chemical, Zhejiang Dongyang Chemical, Medical Chem(Yancheng)Manuf, Wuhan Lullaby Pharmaceutical, Cangzhou Enke Pharma-tech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Report Segments:
The global P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) market is segmented on the basis of:
Types
PurityGreater than or equal to99%, PurityBelow99%
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Esmolol Hydrochloride, Cetraxate Hydrochloride, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Jiangsu Xinxin Chemical
- Zhejiang Dongyang Chemical
- Medical Chem(Yancheng)Manuf
- Wuhan Lullaby Pharmaceutical
- Cangzhou Enke Pharma-tech
 Market Overview.svg)
Highlights of The P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- PurityGreater than or equal to99%
- PurityBelow99%
- By Application:
- Esmolol Hydrochloride
- Cetraxate Hydrochloride
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
P-Hydroxyphenyl-Propionic Acid is a chemical compound with the molecular formula C5H10O2. It is a colorless liquid that has a sour odor. P-Hydroxyphenyl-Propionic Acid is used in research and manufacturing of pharmaceuticals, plastics, and other chemicals.
Some of the key players operating in the p-hydroxyphenyl-propionic acid (cas 501-97-3) market are Jiangsu Xinxin Chemical, Zhejiang Dongyang Chemical, Medical Chem(Yancheng)Manuf, Wuhan Lullaby Pharmaceutical, Cangzhou Enke Pharma-tech.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market - Supply Chain
4.5. Global P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Forecast
4.5.1. P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size (000 Units) and Y-o-Y Growth
4.5.3. P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Absolute $ Opportunity
5. Global P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Type
5.3.1. PurityGreater than or equal to99%
5.3.2. PurityBelow99%
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Application
6.3.1. Esmolol Hydrochloride
6.3.2. Cetraxate Hydrochloride
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Demand Share Forecast, 2019-2026
9. North America P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Application
9.4.1. Esmolol Hydrochloride
9.4.2. Cetraxate Hydrochloride
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Type
9.7.1. PurityGreater than or equal to99%
9.7.2. PurityBelow99%
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Demand Share Forecast, 2019-2026
10. Latin America P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Application
10.4.1. Esmolol Hydrochloride
10.4.2. Cetraxate Hydrochloride
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Type
10.7.1. PurityGreater than or equal to99%
10.7.2. PurityBelow99%
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Demand Share Forecast, 2019-2026
11. Europe P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Application
11.4.1. Esmolol Hydrochloride
11.4.2. Cetraxate Hydrochloride
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size nd Volume Forecast by Type
11.7.1. PurityGreater than or equal to99%
11.7.2. PurityBelow99%
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Demand Share, 2019-2026
12. Asia Pacific P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Application
12.4.1. Esmolol Hydrochloride
12.4.2. Cetraxate Hydrochloride
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Type
12.7.1. PurityGreater than or equal to99%
12.7.2. PurityBelow99%
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Demand Share, 2019-2026
13. Middle East & Africa P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Application
13.4.1. Esmolol Hydrochloride
13.4.2. Cetraxate Hydrochloride
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market Size and Volume Forecast by Type
13.7.1. PurityGreater than or equal to99%
13.7.2. PurityBelow99%
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market: Market Share Analysis
14.2. P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Distributors and Customers
14.3. P-Hydroxyphenyl-Propionic Acid (CAS 501-97-3) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Jiangsu Xinxin Chemical
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Zhejiang Dongyang Chemical
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Medical Chem(Yancheng)Manuf
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Wuhan Lullaby Pharmaceutical
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cangzhou Enke Pharma-tech
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
